Reduction of HIV incidence in men who have sex with men

The Lancet Infectious Diseases

Volumn 10, Issue 10, 2010, Pages 655-656

  Hogg, Robert S ^a   Moore, David M ^b   Michelow, Warren D ^c   Montaner, Julio S G ^c  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

DISEASE TRANSMISSION; EPIDEMIC; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LETTER; MALE HOMOSEXUAL; MORBIDITY; MORTALITY; PRIORITY JOURNAL; VIRUS LOAD; BEHAVIOR CONTROL; HIV INFECTIONS; INCIDENCE; INFECTION CONTROL; MALE; MALE HOMOSEXUALITY; PROCEDURES; TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BEHAVIOR CONTROL; COMMUNICABLE DISEASE CONTROL; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE;

EID: 77957114922     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70200-0     Document Type: Letter

References (15)

1. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008, 300:520-529.
2. HIV/AIDS epi updates, November 2007 2007, Public Health Agency of Canada, Public Health Agency of Canada, Ottawa.
3. Estimates of HIV prevalence and incidence in Canada, 2008 2009, Public Health Agency of Canada, Public Health Agency of Canada, Ottawa.
4. HIV/AIDS Surveillance in Europe: end-year report 2006, no 75 2007, EuroHIV, Institut de veille sanitaire, Saint-Maurice.
5. Herida M, Alix J, Devaux I, et al. HIV/AIDS in Europe: epidemiological situation in 2006 and a new framework for surveillance. Euro Surveill 2007, 12:3312.
6. China 2010 UNGASS country progress report (2008-2009) 2010, Ministry of Health of the People's Republic of China, Ministry of Health of the People's Republic of China, Beijing.
7. Report on the global HIV/AIDS epidemic 2008 2008, UNAIDS, Joint United Nations Programme on HIV/AIDS, Geneva.
8. Le Vu S, Le Strat Y, Barin F, et al. Population-based HIV-1 incidence in France, 2003-08: a modelling analysis. Lancet Infect Dis 2010, published online Sept 9. 10.1016/S1473-3099(10)70167-5.
9. Montaner JSG, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010, 376:532-539.
10. STI/HIV annual report 2008, British Columbia Centre for Disease Control, British Columbia Centre for Disease Control, Vancouver.
11. Sidibé M Challenges in combating the HIV epidemic, combination prevention and the need for new prevention tools. Joining forces in the devlopment of new prevention technologies meeting Nov 4, 2008, UK Department for International Development, London, UK.
12. Outlook report 2010 Joint United Nations Programme on HIV/AIDS, (accessed Aug 27, 2010). http://www.unaids.org/en/KnowledgeCentre/Resources/FeatureStories/archive/2010/20100713_Outlook_launch.asp.
13. Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the international AIDS society-USA panel. JAMA 2010, 304:321-333.
14. De Cock KM, Gilks CF, Lo Y-R, Guerma T Can antiretroviral therapy eliminate HIV transmission?. Lancet 2009, 373:7-9.
15. Anema A, Wood E, Montaner J The use of highly active retroviral therapy to reduce HIV incidence at the population level. CMAJ 2008, 179:13-14.